Ensuring the Sterility & Safety of Medical Devices through Robust Validation Practices and Streamlined Compliance Initiatives all while Addressing Increasing Regulatory Scrutiny Surrounding Sterilization Methodology & Ethylene Oxide Residuals
Across the medical device industry, executives responsible for product sterilization are continually evaluating processes and validation methodologies to ensure cycle optimization while maintaining device sterility for enhanced patient safety. As devices are becoming increasingly complex, ensuring the appropriate sterilization method is selected and properly validated is of utmost importance to maintain compliance. As such, alignment to key regulatory bodies’ expectations through the use of internationally recognized standards, including AAMI and ISO remains critical to the success of timely validation submissions and approvals. Additional regulatory scrutiny will be given to the dissonance between governing bodies in the United States and Europe surrounding both Ethylene Oxide residuals and reusable devices.
The Q1 Productions 5th Annual Medical Device Sterilization Conference will bring together industry leaders, regulatory bodies and solution providers to discuss topics of key importance and timely concern. Via a mix of formats including panel discussions, exchange groups, workshops and traditional presentations, attendees have the opportunity to take away actionable content through engaging sessions and the sharing of best practices. Further and as always, the event will offer a unique networking platform for delegates to connect with a multitude of key experts in the field.
Eric Jahnke | Sr. Marketing Manager | Q1 Productions
312.955.0424 | email@example.com